The 23rd edition records 30% growth in exhibition area
The 23rd edition of PharmaTech Expo 2026 and LabTech Expo 2026 was held from August 20 to 22, 2026, at Gandhinagar, Gujarat. Organised by PharmaTechnologyIndex.com Pvt. Ltd. in association with the Drug Marketing & Manufacturing Association (DMMA), the three-day event brought together pharmaceutical machinery manufacturers, equipment suppliers and other industry stakeholders.
The exhibition covered 30,000 square metres, with more than 453 exhibitors displaying machinery and equipment for the production of drugs and pharmaceutical products. The event attracted around 25,000 visitors and provided a platform for industry players, particularly micro, small and medium enterprises (MSMEs), to explore business opportunities.
Under the MSME PMS Scheme, 60 MSME units participated in the exhibition. The participating units represented Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Uttarakhand, Karnataka, Delhi and Telangana.
Based on feedback received from exhibitors and the response from visitors and business representatives, the organisers estimated that exhibiting companies would have envisaged orders worth Rs. 650 crore during the three-day event.
The exhibition showcased machinery and equipment for pharmaceutical manufacturing, along with laboratory, analytical and packaging equipment. It provided an opportunity for manufacturers and suppliers to display their products and interact with pharmaceutical companies and other industry representatives.
Inauguration and Dignitaries
The expo was inaugurated on August 20, 2026, by Gujarat Deputy Chief Minister Shri. Harsh Bhai Sanghvi. P.P. Shri. Bhailubapu of the All India Saint Committee, Paliyad, and Dr. Prashant Korat, President of the Bharatiya Janata Yuva Morcha, Gujarat State, also graced the function.
In his inaugural address, Deputy Chief Minister Shri. Harsh Bhai Sanghvi congratulated PharmaTechnologyIndex.com Pvt. Ltd. and DMMA for organising the event, which highlighted pharmaceutical machinery, laboratory, analytical and packaging equipment.
He said that India is moving forward to become a hub in the pharmaceutical sector, with Gujarat playing a major role. The State government is making extensive use of technology to provide various approvals to entrepreneurs and create more opportunities for innovation and investment in Gujarat. He added that the organisation of events such as PharmaTech Expo and LabTech Expo has given further momentum to the pharmaceutical industry in the State.
Other dignitaries who attended the event and visited the exhibition to encourage exhibitors and participants included Mr. H.G. Koshia, Former Commissioner, Food and Drug Control Administration, Government of Gujarat; Dr. Ajay Sachan, Deputy Drugs Controller (India), CDSCO Ahmedabad Zonal Office; Dr. Renu Shome, Director, The Council of EU Chambers of Commerce in India; Mr. Vikram Chandwani, General Secretary, DMMA; and Mr. Ramesh Shah, Chairman, PharmaTechnologyIndex.com Pvt. Ltd.
The other dignitaries included Mr. Gajanan Sastry, Secretary General, Karnataka Drugs and Pharmaceuticals Manufacturers’ Association (KDPMA); Dr. Rajesh Gupta, President, Himachal Drugs Manufacturers Association (HDMA); Shri Arun Shukla, Director, Vishwakarma Engineering; Dr. Rakesh Suraj, Director, EEPC India; Mr. Rajat Srivastava, Additional Executive Director, EEPC India; Dr. Pradeep Mattu, Former Joint Commissioner of Drugs, Punjab; Mr. Lalit Goel and Mr. Narendrakumar Ahooja, former State Drugs Controllers of Haryana; and Mr. Rupam Patel, Joint Commissioner, Food and Drug Control Administration, Government of Gujarat.
Seminars on industry challenges and opportunities
A series of industry-focused seminars was organised alongside the exhibition to address key challenges and emerging opportunities in the pharmaceutical sector.
On August 20, experts deliberated on strategies for controlling the flow of Not of Standard Quality (NSQ) drugs. Another session, titled “Mera IPO Kab Aayega?”, discussed the growing interest among pharmaceutical companies in accessing the capital markets.
The seminars provided a platform for industry representatives to discuss current issues and opportunities in pharmaceutical manufacturing and related sectors.
Support from industry organisations
Several major organisations in the pharmaceutical and related industries supported the event. These included i-Hub Gujarat, the Drug Marketing & Manufacturing Association (DMMA), the Federation of Indian Export Organisations (FIEO), The Council of EU Chambers of Commerce in India, and the Ambala Scientific Instruments Manufacturers’ Association (ASIMA), along with other industry associations and industrial houses.
Their participation and support contributed to bringing together manufacturers, suppliers and other stakeholders from across the pharmaceutical industry.
Gujarat's pharmaceutical industry
Gujarat has a significant presence in India’s pharmaceutical manufacturing sector. According to the information provided by the organisers, the Gujarat Food and Drugs Control Administration (FDCA) has issued approximately 5,611 manufacturing licences, of which around 986 are WHO-GMP compliant, while about 140 units have USFDA approval. The State has also issued 6,38,105 licences for drug products to date.
Gujarat accounts for approximately one-third of India’s pharmaceutical exports, with a substantial contribution from the MSME sector.
Alongside large and medium-scale industrial projects engaged in drug and pharmaceutical production, the State has around 7,000 small-scale manufacturing units contributing to its pharmaceutical production. The major developing segments of the industry include formulations, biotechnology, nutraceuticals, cosmeceuticals, ayurveda and herbal products.
Growth in exhibition area and visitor participation
With the cooperation of the industry, PharmaTech Expo 2026 recorded 30% growth in exhibition area and approximately 10% growth in visitor numbers compared with the previous year’s edition in 2025.
The three-day exhibition and seminar programme provided a platform for industry stakeholders to understand current issues and opportunities in pharmaceutical machinery and pharmaceutical products, particularly for the MSME sector in the region.
The participation of exhibitors from several States, industry associations and representatives of the pharmaceutical sector helped bring together different stakeholders and provided opportunities for business interactions and the exchange of industry knowledge.